How is the Cogent Biosciences Inc today?

The Cogent Biosciences Inc today is trading in the green, up by 1.98% at 7.21.

How has Cogent Biosciences Inc performed historically?

The Cogent Biosciences Inc is currently trading up 1.98% on an intraday basis in the past week the index fell -0.41%. The index has been up 4.49% in the past quarter and fell -13.13% in the past year. You can view this in the overview section.

What is Cogent Biosciences Inc Annual Net Profit?

Cogent Biosciences Inc Annual Net Profit fell 32.98% in the last year to $255.86 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Cogent Biosciences Inc Price to Earning Ratio?

Cogent Biosciences Inc Price to Earning Ratio is -3.05, which is negative.

What is Cogent Biosciences Inc Stock Price?

Cogent Biosciences Inc Stock Price fell 13.13% and underperformed its sector by 64.27% in the past year.

What is Cogent Biosciences Inc Quarterly Net profit?

Cogent Biosciences Inc Quarterly Net profit fell 23.37% YoY to $71.99 M. Its sector's average net profit growth YoY for the quarter was -236.03%.

What is Cogent Biosciences Inc Debt to Equity Ratio?

Cogent Biosciences Inc Debt to Equity Ratio of 0.12 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Cogent Biosciences Inc Return on Equity(ROE)?

Cogent Biosciences Inc Return on Equity(ROE) for the last financial year was -148.99%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Cogent Biosciences Inc Mutual Fund Holding?

Cogent Biosciences Inc Mutual Fund Holding increased by 0.41% in the last quarter to 42.19.

What is Cogent Biosciences Inc Promoter Share Holding?

Cogent Biosciences Inc Promoter Share Holding stayed the same in the most recent quarter at 0.17%.

What is Cogent Biosciences Inc Institutional Holding?

Cogent Biosciences Inc Institutional Holding increased by 10.45% in the last quarter to 116.87.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
COGENT BIOSCIENCES INC

Cogent Biosciences Inc XNAS: COGT

Cogent Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Cogent Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Cogent Biosciences Inc
Rating: 1.17850
Author: Trendlyne DVM scores

about

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its progr...

7.21 0.14 (1.98%)

42.82% Fall from 52W High

373.9K

XNAS Volume

XNAS 26 Jun, 2025 10:54 AM (EDT)

Not Eligible

Expensive Valuation

3.0 / 100

Technically Neutral

44.1 / 100

No estimates available

Cogent Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cogent Biosciences Inc Live Share Price Today, Share Analysis and Chart

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its progr...

42.82% Fall from 52W High

SWOT Analysis

Cogent Biosciences Inc Live Price Chart

Cogent Biosciences Inc FAQ

How is Cogent Biosciences Inc today?

Cogent Biosciences Inc today is trading in the green, and is up by 1.98% at 7.21.

How has Cogent Biosciences Inc performed historically?

Cogent Biosciences Inc is currently trading up 1.98% on an intraday basis. In the past week the stock fell -0.41%. stock has been up 4.49% in the past quarter and fell -13.13% in the past year. You can view this in the overview section.